Necrotizing pancreatitis in a COVID-19 patient managed with endoscopic AXIOS stent placement
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
As coronavirus disease 2019 (COVID-19) is a relatively novel infectious process, atypical presentations like acute pancreatitis (AP) are still being studied and a clear association between pancreatic injury and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has yet to be established. This makes the diagnosis and management of such conditions exceedingly difficult. Although several cases of severe AP with concurrent SARS-CoV-2 infection have been reported, to the best of our knowledge, ours is the first COVID-19 case to present with necrotizing pancreatitis and the first reported case requiring intervention for associated local complications.
Abstract
As coronavirus disease 2019 (COVID-19) is a relatively novel infectious process, atypical presentations like acute pancreatitis (AP) are still being studied and a clear association between pancreatic injury and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has yet to be established. This makes the diagnosis and management of such conditions exceedingly difficult. Although several cases of severe AP with concurrent SARS-CoV-2 infection have been reported, to the best of our knowledge, ours is the first COVID-19 case to present with necrotizing pancreatitis and the first reported case requiring intervention for associated local complications.
참고문헌 (15)
- Ahmad FB, "Provisional mortality data-United States, 2020", MMWR Morb Mortal Wkly Rep, 70, pp.519~522 (2021)
- de-Madaria E, "COVID-19 and acute pancreatitis : examining the causality", Nat Rev Gastroenterol Hepatol, 18, pp.3~4 (2021)
- Wang F, "Pancreatic injury patterns in patients with coronavirus disease 19 Pneumonia", Gastroenterology, 159, pp.367~370 (2020)
- Wolfe D, "Drug induced pancreatitis : a systematic review of case reports to determine potential drug associations", PLoS One, 15, pp.e0231883~ (2020)
- Dholakia K, "How often are liver function tests normal in acute biliary pancreatitis?", J Clin Gastroenterol, 38, pp.81~83 (2004)
- Jones MR, "Drug-induced acute pancreatitis : a review", Ochsner J, 15, pp.45~51 (2015)
- George J, "Incidence of pancreatitis with the use of immune checkpoint inhibitors(ICI)in advanced cancers : a systematic review and meta-analysis", Pancreatology, 19, pp.587~594 (2019)
- Gupta V, "COVID-19 and acute pancreatitis: what do surgeons need to know?", Indian J Surg (2020)[DOI]
- Liu F, "ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection", Clin Gastroenterol Hepatol, 18, pp.2128~2130 (2020)
- Kumar V, "Clinical course and outcome among patients with acute pancreatitis and COVID-19", Eur J Gastroenterol Hepatol, 33, pp.695~700 (2021)
- Banks PA, "Classification of acute pancreatitis--2012 : revision of the Atlanta classification and definitions by international consensus", Gut, 62, pp.102~111 (2013)
- Lax SF, "Pulmonary arterial thrombosis in COVID-19 with fatal outcome : results from a prospective, single-center, clinicopathologic case series", Ann Intern Med, 173, pp.350~361 (2020)
- Miró Ò, "A casecontrol emergency department-based analysis of acute pancreatitis in Covid-19 : results of the UMC-19-S6", J Hepatobiliary Pancreat Sci, 28, pp.953~966 (2021)
- Pandanaboyana S, "SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality : COVID PAN collaborative study", Gut, 70, pp.1061~1069 (2021)
- Gadiparthi C, "Hyperglycemia, hypertriglyceridemia, and acute pancreatitis in COVID-19 infection : clinical implications", Pancreas, 49, pp.e62~3 (2020)